Sanofi, through its philanthropic organization Foundation S, and Sobi, together with the World Federation of Haemophilia (WFH) and WFH USA, announce the signing of a contract providing support to the WFH
SOBI is a Sweden-based biopharmaceutical company that discovers and develops novel therapies for the treatment of diseases such as hemophilia and cancer.